Search Results 611-620 of 17370 for Break STD Taboo

  1. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  2. A Study to Evaluate The Effectiveness and Safety of Abrocitinib, with or without Topical Medications, in Subjects Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  3. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  4. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  5. Publications - Brad B. Smith, M.D. - Mayo Clinic

    A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS ...

  6. Medical Research & Education - Mayo Clinic News Network

    Discovery's Edge: Before the Bone Breaks featured image. Research. Discovery's Edge: Before the Bone Breaks. Mayo Clinic Staff. July 12, 2016. Estrogen Patch in ...

  7. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

    ... standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes a "non ...

  8. Clinical trials - Gastroenterology and Hepatology

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  9. A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  10. News - Brad J. Stish, M.D. - Mayo Clinic

    Search for a doctor. Brad J. Stish, M.D.. Radiation Oncologist. Request an Appointment · Overview · News · Publications. News.